Potential role of ADAM (A Disintegrin And Metalloprotease) in malignant pleural mesothelioma resistance to chemotherapy.

M. Bellefroid (Liege, Belgium), C. Sépult (Liege, Belgium), C. Vanwinge (Liege, Belgium), A. Gillard (Liege, Belgium), B. Duysinx (Liege, Belgium), C. Poulet (Liege, Belgium), A. Debit (Liege, Belgium), A. Noel (Liege, Belgium), D. Cataldo (Liege, Belgium)

Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside
Session: Novel directions in pleural disease: bench to bedside
Session type: E-poster session
Number: 1136
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Bellefroid (Liege, Belgium), C. Sépult (Liege, Belgium), C. Vanwinge (Liege, Belgium), A. Gillard (Liege, Belgium), B. Duysinx (Liege, Belgium), C. Poulet (Liege, Belgium), A. Debit (Liege, Belgium), A. Noel (Liege, Belgium), D. Cataldo (Liege, Belgium). Potential role of ADAM (A Disintegrin And Metalloprotease) in malignant pleural mesothelioma resistance to chemotherapy.. 1136

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Expression of A Disintegrin and Metalloprotease (ADAM) enzymes in human squamous cell lung carcinomas
Source: Eur Respir J 2004; 24: Suppl. 48, 704s
Year: 2004

Expression of adamalysin proteases (A Disintegrin And Metalloprotease) and their inhibitors in sputum from asthmatics
Source: Eur Respir J 2006; 28: Suppl. 50, 445s
Year: 2006

ADAM10 membrane-bound protease mediates malignant pleural mesothelioma invasiveness
Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management
Year: 2018

Aminopeptidase N/CD13 as a potential therapeutic target in malignant pleural mesothelioma
Source: Eur Respir J, 51 (5) 1701610; 10.1183/13993003.01610-2017
Year: 2018



A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma
Source: Eur Respir J 2010; 36: 1099-1105
Year: 2010



Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016


A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAMTS18) is a novel regulator of BPD
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018


Metalloproteinases, tissue inhibitors of metalloproteinases and TGF-β as predictors of pleura thickening in pleural tuberculosis
Source: Annual Congress 2009 - Diagnostic advances in tuberculosis
Year: 2009


Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions
Source: Eur Respir J 2005; 25: 104-109
Year: 2005



Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM)
Source: Eur Respir J 2004; 24: Suppl. 48, 81s
Year: 2004

Multimodal therapy in malignant pleural mesothelioma (MPM)
Source: Eur Respir J 2002; 20: Suppl. 38, 187s
Year: 2002

Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in pleural effusions
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011


Matrix metalloproteinases (MMPs) and angiogenesis in lung tissue remodeling in different variants of idiopathic interstitial pneumonia (IIP)
Source: Eur Respir J 2007; 30: Suppl. 51, 137s
Year: 2007

Over-expression of chloride intracellular channels (CLICs) 3 and 4 in malignant pleural mesothelioma
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013

Role of tumor derived versican in experimental malignant pleural mesothelioma
Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside
Year: 2016

RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer
Source: Eur Respir J 2012; 39: 677-684
Year: 2012



The role of matrix metalloproteinase- 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMMP-1) in sarcoidosis and idiopathic pulmonary fibrosis. Correlation with echocardiography
Source: Eur Respir J 2006; 28: Suppl. 50, 745s
Year: 2006

Targeting of CSF1R abrogates Lewis Lung adenocarcinoma-induced malignant pleural effusion
Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management
Year: 2018

The metallopeptidase neprilysin is a hypoxia-induced prognostic factor in lung adenocarcinoma
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012

Metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor (TGFβ) in pleural tuberculosis
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008